首页 | 本学科首页   官方微博 | 高级检索  
     


Neurofeedback for Attention-Deficit/Hyperactivity Disorder: 25-Month Follow-up of Double-Blind Randomized Controlled Trial
Affiliation:1. Assistant Professor of Psychiatry and Pediatrics, University of Pittsburgh Medica Center, Western Psychiatric Hospital;2. Assistant Professor of Psychiatry and OB-GYN, University of California, Los Angeles;1. Sunnybrook Health Sciences Centre, University of Toronto, Ontario, Canada;1. Bellvitge Biomedical Research Institute-IDIBELL, Bellvitge University Hospital, Barcelona, Spain;2. CIBERSAM, Barcelona, Spain;3. University of Barcelona, Barcelona, Spain;4. CIBERobn, ISCIII, Spain;5. McLean Hospital, Belmont, Massachusetts;6. Harvard Medical School, Boston, Massachusetts;7. Image Diagnostic Center, Hospital Clinic, Barcelona, Spain;8. Magnetic Resonance Image Core Facility (IDIBAPS), Barcelona, Spain;9. Hospital das Clinicas HCFMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil;10. Pontificial Catholic University of Sao Paulo, Brazil;11. Amsterdam UMC, Location VUmc, Amsterdam, the Netherlands;12. University of California Los Angeles, Los Angeles, California;13. University of Toronto, Canada;14. Centre for Addiction and Mental Health, Toronto, Canada;15. Karolinksa Institutet, Stockholm, Sweden;p. Columbia University, New York;q. The New York State Psychiatric Institute, New York;r. Columbia University Medical College, Columbia University, New York;s. Bergen Center for Brain Plasticity, Haukeland University Hospital, Bergen, Norway;t. Centre for Crisis Psychology, University of Bergen, Bergen, Norway;u. Research Center for Child Mental Development, Chiba University, Chiba, Japan;v. United Graduate School of Child Development, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University and University of Fukui, Suita, Japan;w. LiNC - Laboratory of Integrative Neuroscience of Universidade Federal de São Paulo (UNIFESP), Brazil;x. Levvel, Academic Center for Child and Adolescent Psychiatry, Amsterdam, the Netherlands;y. Amsterdam UMC, Amsterdam, the Netherlands;z. Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC, Marina del Rey, California;11. University of British Columbia, Vancouver, Canada;12. British Columbia Children''s Hospital Research Institute, Vancouver, Canada;13. University of Bergen, Bergen, Norway;14. IDIBAPS, Barcelona, Spain;15. Hospital Clínic, Barcelona, Spain;16. Life and Health Sciences Research Institute (ICVS), University of Minho, Braga, Portugal;17. ICVS/3B''s, PT Government Associate Laboratory, Braga/Guimarães, Portugal;18. Clinical Academic Center - Braga, Braga, Portugal;19. University of Michigan, Ann Arbor;110. UCLA Division of Child and Adolescent Psychiatry, Los Angeles, California;111. UCLA Brain Research Institute, Los Angeles, California;112. University of Illinois at Urbana Champaign, Champaign, Illinois;113. UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, California;114. British Columbia Mental Health and Substance Use Services Research Institute, Vancouver, Canada;115. University Hospital of Psychiatry Zurich, University of Zurich, Switzerland;1p. Neuroscience Center Zurich, University of Zurich and ETH Zurich, Switzerland;1q. Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam, the Netherlands;1r. SAMRC Unit on Risk and Resilience in Mental Disorders, Neuroscience Institute, University of Cape Town, Cape Town, South Africa
Abstract:
Keywords:ADHD  neurofeedback  double-blind randomized clinical trial  long-term follow-up  EEG biofeedback
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号